Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC)

Q: What does CUSIP 68622P109 represent in this 13F holders report?

CUSIP 68622P109 is the security identifier for ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share used to aggregate holder disclosures.

Q: How many institutions held ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in Q2 2020?

64 institutional investors reported ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share for Q2 2020. Use the holders table for investor-level position and value details.

CUSIP: 68622P109

Q2 2020 13F Holders as of 30 Jun 2020

Type / Class: Equity / Common Stock, par value $0.0001 per share
Shares outstanding: 97,866,034
Total 13F shares: 21,388,813
Share change: +21,388,813
Total reported value: $718,339,063
Price per share: $33.73
Number of holders: 64
Value change: +$718,339,063
Number of buys: 64

Quarterly Holders Quick Answers

What is CUSIP 68622P109?
CUSIP 68622P109 identifies ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q3 2020

Recent filing periods for CUSIP 68622P109:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of ORIC - Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

No top shareholder records were found across 13F, 13D/G, and Forms 3/4/5 for this issuer.

Institutional Holders of Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) as of Q2 2020

As of 30 Jun 2020, Oric Pharmaceuticals, Inc. - Common Stock, par value $0.0001 per share (ORIC) was held by 64 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 21,388,813 shares. The largest 10 holders included Svennilson Peter, FMR LLC, ORBIMED ADVISORS LLC, EcoR1 Capital, LLC, Invus Financial Advisors, LLC, BlackRock Inc., WELLS FARGO & COMPANY/MN, VICTORY CAPITAL MANAGEMENT INC, Foresite Capital Management III, LLC, and VANGUARD GROUP INC. This page lists 64 institutional shareholders reporting positions in this security for the Q2 2020 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q2 2020 vs Q4 2025 Across Filers

Q4 2025 holders

165

Q2 2020 holders

Holder diff

-101

Investor	Q4 2025 Shares	Q2 2020 Shares	Share Diff	Share Chg %	Q4 2025 Value $	Q2 2020 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.